Cadence Wealth Management’s Boston Scientific BSX Stock Holding History

Cadence Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,890	Closed	-$370K	–	64
2026 Q1	$370K	Hold	5,890	–	–	0.15%	46
2025 Q4	$562K	Hold	5,890	–	–	0.27%	37
2025 Q3	$575K	Hold	5,890	–	–	0.3%	36
2025 Q2	$633K	Hold	5,890	–	–	0.42%	31
2025 Q1	$594K	Hold	5,890	–	–	0.44%	25
2024 Q4	$526K	Hold	5,890	–	–	0.35%	28
2024 Q3	$494K	Hold	5,890	–	–	0.4%	25
2024 Q2	$454K	Hold	5,890	–	–	0.32%	30
2024 Q1	$403K	Hold	5,890	–	–	0.41%	26
2023 Q4	$341K	Hold	5,890	–	–	0.27%	29
2023 Q3	$311K	Hold	5,890	–	–	0.26%	30
2023 Q2	$319K	Hold	5,890	–	–	0.31%	23
2023 Q1	$295K	Buy	+5,890	New	+$278K	0.3%	21

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cadence Wealth Management's BSX Position: Q2 2026 in Review

Cadence Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,890 shares — an estimated $370K sold.

Cadence Wealth Management first reported a position in BSX in Q1 2023 and held it in 13 quarters. The position peaked at $633K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cadence Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Cadence Wealth Management sold 5,890 Boston Scientific shares in Q2 2026, an estimated $370K.
Cadence Wealth Management first reported a position in Boston Scientific in Q1 2023 and held it in 13 quarters.
Cadence Wealth Management's Boston Scientific position peaked at $633K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cadence Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.